PJP: Healthcare Dashboard For March

Fred PiardInvesting Group LeaderFollow5ShareSavePlay(8min)CommentsSummaryHealthcare subsectors are undervalued as a whole based on 11-year averages.Invesco Pharmaceuticals ETF offers a multi-factor, value-oriented approach to the pharmaceutical industry, outperforming XPH and XLV since 2006.PJP is suitable for both long-term and tactical allocations, supported by sufficient liquidity and a robust historical risk-return profile.10 healthcare stocks cheaper than their peers in March.Quantitative Risk & Value members get exclusive access to our real-world portfolio. See all our investments here » Pakawadee Wongjinda/iStock via Getty Images This monthly article series offers a top-down view of the healthcare sector based on value, quality, and momentum metrics. It may also help analyze sector ETFs such as Health Care Select Sector SPDR ETF (This article was written byFred Piard16.35K FollowersFollowFred Piard, PhD. is a quantitative analyst and IT professional with over 30 years of experience working in technology. He is the author of three books and has been investing in data-driven systematic strategies since 2010. Fred runs the investing group Quantitative Risk & Value where he shares a portfolio invested in quality dividend stocks, and companies at the forefront of tech innovation. Fred also supplies market risk indicators, a real estate strategy, a bond strategy, and an income strategy in closed-end funds. Learn more.Analyst’s Disclosure: I/we have a beneficial long position in the shares of AMGN, GILD, MRK either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.